Jill M. Seargent

GW9662, a potent antagonist of PPAR<i>γ</i>, inhibits growth of breast tumour cells and promotes the anticancer effects of the PPAR<i>γ</i> agonist rosiglitazone, independently of PPAR<i>γ</i> activation

Jill M. Seargent, Elisabeth Yates, Jason H. Gill · British Journal of Pharmacology · 2004 · 188 citations · Full text

Medicine, Oncology, Pharmacology +15

Cytochrome P450 1B1 (CYP1B1) is overexpressed in human colon adenocarcinomas relative to normal colon: implications for drug development.

Paul Gibson, Jason H. Gill, Parveen A Khan et al. · PubMed · 2003 · 89 citations

Medicine, Oncology, Pharmacology +12

MMP-10 Is Overexpressed, Proteolytically Active, and a Potential Target for Therapeutic Intervention in Human Lung Carcinomas

Jason H. Gill, Ian G. Kirwan, Jill M. Seargent et al. · Neoplasia · 2004 · 62 citations · Full text

Medicine, Oncology, Pathology +17

Expression of matrix metalloproteinase-10 in human bladder transitional cell carcinoma

Jill M. Seargent, Paul M. Loadman, Sandie Martin et al. · Urology · 2005 · 30 citations · Full text

Medicine, Oncology, Urology +10

Immunohistochemical analysis of NAD(P)H:quinone oxidoreductase and NADPH cytochrome P450 reductase in human superficial bladder tumours: Relationship between tumour enzymology and clinical outcome following intravesical mitomycin C therapy

Saurajyoti Basu, John E. Brown, G. Michael Flannigan et al. · International Journal of Cancer · 2004 · 27 citations · Full text

Medicine, Oncology, Pharmacology +17